MarketPeel
Insider Trading Intelligence
GC

Gillian Cannon

XENE
DIRECTOR · XENON PHARMACEUTICALS INC. · CIK 0001833910
FILING MIX · LIFETIME74%/26%
BUYS
14
SELLS
5
TOTAL VALUE
$569.1K
COMPANIES
2
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
1,455
AVG SELL PX
$65.92
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Gillian Cannon. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
XENE · 1,455 shares · as of Jun 5, 2026
07,00014,00021,00028,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 5 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
XENE
XENON PHARMACEUTICALS INC.
SALE10b5-1
10b5-1 plan
1,190$53.14$63.2K1,455Jun 5, 2026Jun 8, 2026View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,50710,507Jun 3, 2026Jun 3, 2026View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
1,5931,593Jun 3, 2026Jun 3, 2026View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASE
2,6452,645Jun 1, 2026Jun 3, 2026View →
XENE
XENON PHARMACEUTICALS INC.
SALE
2,6450Jun 1, 2026Jun 3, 2026View →
CORT
CORCEPT THERAPEUTICS INC
SALEGRANT
Gift
7,3930Sep 10, 2025Sep 11, 2025View →
CORT
CORCEPT THERAPEUTICS INC
SALE
11,00049,000Sep 4, 2025Sep 8, 2025View →
CORT
CORCEPT THERAPEUTICS INC
SALE
3,607$70.13$253.0K7,393Sep 4, 2025Sep 8, 2025View →
CORT
CORCEPT THERAPEUTICS INC
PURCHASE
11,000$22.99$252.9K11,000Sep 4, 2025Sep 8, 2025View →
CORT
CORCEPT THERAPEUTICS INC
PURCHASEGRANT
Stock grant
15,00015,000Jun 10, 2025Jun 12, 2025View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
2,6452,645Jun 5, 2025Jun 6, 2025View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
17,01217,012Jun 5, 2025Jun 6, 2025View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
15,54215,542Jun 5, 2024Jun 5, 2024View →
CORT
CORCEPT THERAPEUTICS INC
PURCHASEGRANT
Stock grant
30,00030,000May 17, 2024May 21, 2024View →
XENE
XENON PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
28,00028,000Aug 10, 2023Aug 10, 2023View →
CORT
CORCEPT THERAPEUTICS INC
PURCHASEGRANT
Stock grant
30,00030,000May 19, 2023May 23, 2023View →
CORT
CORCEPT THERAPEUTICS INC
PURCHASEGRANT
Stock grant
20,00020,000May 31, 2022Jun 2, 2022View →
CORT
CORCEPT THERAPEUTICS INC
PURCHASEGRANT
Stock grant
20,00020,000May 26, 2021May 28, 2021View →
CORT
CORCEPT THERAPEUTICS INC
PURCHASEGRANT
Stock grant
60,00060,000Dec 1, 2020Dec 2, 2020View →
Other insiders · XENE
Loading peer insiders…
About this filer
CIK 0001833910
ROLE
Director
PRIMARY
XENE
COMPANIES
2
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001833910DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback